Merck Frosst
Patients & Caregivers Contact Us Français
Patients & CaregiversContact UsFrançais
Home

VARIVAX® III

[varicella virus vaccine, live, attenuated (Oka/Merck)]

Disclaimer

Original Notice of Compliance (NoC)

VARIVAX® III : June 26, 2002
VARIVAX® II : August 26, 1999
VARIVAX®: December 2, 1998

Therapeutic / Pharmacological Classification

Vaccine for Active Immunization Against Varicella (Chickenpox)

Product Monograph / Prescribing Information / Product Information

Download   Date of Approval: February 27, 2009 (09, 02-a_126333)
File name: VARIVAX_0902-a_126333-E.pdf
File size: 171 KB

CONSUMER INFORMATION

Download   Date of Approval: February 27, 2009 (09, 02-a_126333)
File name: VARIVAX_0902-a_126333-CI-E.pdf
File size: 82 KB


This file is presented in PDF format.  This software is available at no charge through the Adobe Web site.  Get Adobe Reader

DISCLAIMER
The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for informational purposes only and are intended solely for residents of Canada, and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition.


® Registered Trademark of Merck & Co., Inc. Used under license.

Printer friendly
Email a friend

This site is for residents of Canada. / This site was updated on August 25, 2010.